Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DX25F6AFU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $47,715
Award facts
- Contract value 100% obligated
- $47,714.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On September 15, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $47,714.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a total contract value of $499.999 billion and remains valid through November 2026. The delivery order is scheduled for completion by October 6, 2025, with performance taking place at the contractor's facilities in Park Ridge, Illinois. No set-aside designation was applied to this award.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts to deliver a broad portfolio of pharmaceutical products to military healthcare facilities nationwide. The company's core business involves distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables directly to Department of Defense healthcare sites. EXPAREL, a liposomal bupivacaine anesthetic product, represents the type of specialized pharmaceutical product the company regularly procures for federal customers. The DMS Pharmaceutical Group's woman-owned small business status has enabled the firm to compete effectively in federal procurement markets while maintaining its position as a primary pharmaceutical distributor to the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DX25F6AFU?
SPE2DX25F6AFU was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 15, 2025.
How much is contract SPE2DX25F6AFU worth?
The government has obligated $47,715 on SPE2DX25F6AFU.
Is contract SPE2DX25F6AFU an order under another contract?
Yes. SPE2DX25F6AFU is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AFU competed?
The extent of competition for SPE2DX25F6AFU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award